πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 3,063 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8105609

Flavivirus immunogens comprising extracellular viral particles composed of the premembrane

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention Β· Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8105598

Human monoclonal antibodies that specifically bind IGF-II

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jan 31 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8101380

Schizophrenia-related isoform of KCNH2 and development of antipsychotic drugs

The United States of America, as represented by the Secretary, Health and Human Services Β· Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8101739

Recombinant expression vectors comprising a human codon-optimized marburg virus (MARV) ang

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8101172

Solenopsis invicta virus

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Jan 24 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8093343

Nitric oxide-releasing diazeniumdiolated compounds

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8092809

Pseudomonas exotoxin A-like chimeric immunogens

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Jan 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8088787

Methods related to the treatment of neurodegenerative and inflammatory conditions

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8088729

Anti-viral griffithsin compounds, compositions and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8088379

Modified T cell receptors and related materials and methods

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Jan 03 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8084594

H2N3 influenza A viruses and methods of use

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8084415

Uteroglobin in the treatment of IGA mediated nephropathy

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8084250

Defensin-antigen fusion proteins

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8084199

Method of diagnosing poor survival prognosis colon cancer using microRNA-21

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, NATIONAL INSTITUTES OF HEALTH Β· Granted Tue Dec 27 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8080554

Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Dec 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8076100

Molecular clones with mutated HIV gag/pol, SIV gag and SIV env genes

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8075921

Rapamycin-resistant T cells and therapeutic uses thereof

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8075903

Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3β€²-UTR of den

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8075900

Melanoma associated peptide analogues and vaccines against melanoma

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 13 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8071746

Isolated nucleic acid molecule encoding a peptide or peptide analog comprising the SEQ ID

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8071323

Human monoclonal antibodies that bind human insulin like growth factors and their use

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8071113

Live, oral vaccine for protection against Shigella dysenteriae serotype 1

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8071084

Vaccine for protection against Shigella sonnei disease

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Dec 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8067563

Tumor suppressor gene, p471NG3

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Nov 29 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted